Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Common skin conditions can greatly affect a person's mental health and social life.

Topical minoxidil and oral finasteride can help regrow hair in androgenetic alopecia.

The herbal mixture Xiantene may help treat common baldness, and men who grey early tend to be less bald but more grey.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Trichotillomania involves hair pulling and can be treated with therapy and medication.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

More compassion satisfaction reduces emotional exhaustion in caregivers.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Stopping zolpidem improved hair loss caused by self-inflicted scalp injuries during sleep.

Inclusive dermatology aims to provide personalized skin care for all by addressing diverse needs and disparities.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Smoking and alcohol worsen hair transplant results.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.